Article
Elexacaftor/Tezacaftor/Ivacaftor alters branching morphogenesis of the mouse embryonic lung
2021-11-04
Abstract excerpt
<h4>Introduction</h4> CFTR modulators triple combo-therapy Elexacaftor/Tezacaftor/Ivacaftor (ETI) has proven to clinically benefit homozygous and heterozygous F508del patients. As a result, an increasing number of pregnancies is expected. Studies of the potential impact of these modulators on the development of the foetus are mandatory. <h4>Materials</h4> We used the early mouse embryonic lung organ culture mode...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d283c23f-0181-5998-be67-5257eb611486
- DOI
- 10.1101/2021.11.01.466814
